# Digital Twins in Healthcare: Real Uses, Data Needs, and Limits > Digital twins in healthcare can support planning, simulation, operations, and personalized care, but only when the data model, governance, and validation plan are serious. - Author: Vladimir Terekhov - Published: 2026-06-11 - Canonical: https://attractgroup.com/blog/digital-twins-in-healthcare/ - Markdown: https://attractgroup.com/blog/digital-twins-in-healthcare.md The term "digital twin" has traveled from aerospace engineering to healthcare conference stages in about five years. Along the way, it picked up a lot of vendor polish and not enough technical specificity. Digital twins in healthcare refer to computational models that mirror a physical system, whether that system is a patient, an organ, a hospital floor, or a supply chain, and update continuously with real-world data. The concept is sound. The gap between concept and production-grade implementation is where most projects stall. This article covers what healthcare digital twins actually require, which use cases are working today, and where the limits sit. If you are evaluating whether to invest engineering effort here, the goal is to give you a realistic frame. ## What a healthcare digital twin actually is A digital twin is a dynamic computational model bound to a specific physical counterpart through ongoing data exchange. That last part matters. A static simulation of a heart valve is a model. A simulation that ingests a specific patient's imaging, hemodynamic data, and medication history, then updates as new readings arrive, starts to qualify as a digital twin. The [NIH Office of Data Science and Strategy](https://datascience.nih.gov/tools-and-analytics/digital-twins) frames digital twins as tools that combine heterogeneous data sources with mechanistic or machine-learning models to represent biological and clinical systems. The emphasis is on continuous feedback: the twin reflects the current state of its counterpart, not a snapshot from last quarter. In practice, most healthcare "digital twins" today sit on a spectrum: - **Parametric models** that take patient-specific inputs and run simulations (e.g., cardiac electrophysiology models tuned to individual anatomy). - **Operational twins** that mirror hospital workflows, bed occupancy, or equipment status in near-real-time. - **Population-level synthetic cohorts** used for trial simulation or resource planning. Each type has different data requirements, different validation burdens, and different regulatory exposure. Lumping them together under one label causes confusion in planning and procurement. ## Digital twin use cases that are realistic now Some applications have moved past the proof-of-concept stage. Others remain firmly in research. Knowing the difference saves months of misdirected effort. ### Operational and facility twins Hospital operations are the most mature area. Modeling patient flow, staffing patterns, bed turnover, and equipment utilization against real-time feeds from EHR and scheduling systems is achievable with current infrastructure. These twins help administrators test "what if" scenarios: what happens to ED wait times if we add four observation beds, or how does a 15% nursing shortage on night shift affect discharge timing? The data requirements are well-understood (ADT feeds, scheduling data, staffing rosters), and the regulatory burden is low because these models do not make clinical decisions about individual patients. ### Organ and physiology models Patient-specific cardiac models are the most cited clinical example. Companies and research groups have built twins that simulate blood flow, valve mechanics, or arrhythmia propagation using a combination of imaging data and physics-based models. Some of these are used in surgical planning. The [NSF, NIH, and FDA have jointly funded research](https://www.nsf.gov/news/nsf-nih-fda-support-research-digital-twin-technology) into biomedical digital twin technology, which signals institutional seriousness but also confirms that much of this work is still foundational. Production deployment for individual clinical decisions remains narrow. ### Drug development and trial simulation Pharmaceutical companies use population-level digital twins to simulate clinical trial arms, test dosing strategies, or model disease progression. The FDA has shown interest in synthetic control arms derived from digital twin approaches, though acceptance varies by therapeutic area and submission context. ### Chronic disease monitoring Longitudinal models that track a patient's diabetes management, heart failure trajectory, or COPD exacerbation risk by integrating wearable sensor data, lab results, and medication adherence signals. These are promising but face serious data continuity problems. Wearable data is noisy, intermittent, and rarely standardized. Clinical data arrives in bursts around encounters. Stitching these into a coherent temporal model is harder than most pitch decks suggest. ## The data foundation most projects underestimate Every digital twin project is a data integration project first. The modeling and simulation layer gets the attention, but the data pipeline determines whether the twin reflects reality or drifts into fiction. ### What the twin needs to consume Depending on the use case, inputs may include: - EHR structured data (diagnoses, labs, vitals, medications, procedures) - Imaging data (DICOM, with segmentation and annotation) - Continuous monitoring streams (wearables, ICU telemetry, RPM devices) - Operational data (ADT, scheduling, claims) - Genomic or proteomic profiles - Patient-reported outcomes ### Where projects break down **Interoperability gaps.** Most health systems still struggle with basic data exchange between their own internal platforms. Building a twin that requires synchronized feeds from an EHR, a PACS, a wearable platform, and a lab information system means solving [interoperability in healthcare](https://attractgroup.com/blog/interoperability-in-healthcare/) problems before you can solve modeling problems. FHIR helps, but coverage is uneven and real-time FHIR subscriptions are not universally supported. **Temporal alignment.** A lab value drawn at 7 AM, a blood pressure reading from a wearable at 7:03 AM, and a medication administration record timestamped at 7:15 AM all describe the same patient window but arrive through different systems with different latencies and different timestamp conventions. Aligning these into a coherent state vector is nontrivial. **Data quality and missingness.** Clinical data is incomplete by nature. Patients skip appointments, sensors disconnect, clinicians document inconsistently. A twin that cannot degrade gracefully when 40% of expected inputs are missing is not ready for production. **Consent and governance.** Continuous data collection from wearables and home devices raises consent questions that go beyond standard HIPAA authorization. Patients need to understand what the twin does with their data, how long it persists, and who can query it. ## Validation, safety, and regulatory questions A digital twin that informs a clinical decision about a specific patient is, functionally, software that contributes to diagnosis or treatment. The [FDA's framework for Software as a Medical Device (SaMD)](https://www.fda.gov/medical-devices/digital-health-center-excellence/software-medical-device-samd) applies when software is intended to be used for medical purposes without being part of a hardware device. ### When does a twin become SaMD? If your twin recommends a drug dosage adjustment, predicts a clinical deterioration event, or guides a surgical plan, it likely falls under SaMD. If it models hospital bed capacity or simulates population-level trends for administrative planning, it probably does not. The distinction matters for: - **Validation requirements.** SaMD needs clinical validation, not just technical verification. You must demonstrate that the twin's outputs improve or at least do not harm clinical outcomes. - **Change management.** Every model update, retraining cycle, or data source change may require re-validation. - **Transparency.** Clinicians need to understand what the twin is doing and where its confidence is low. Black-box twins that output a single recommendation without uncertainty bounds are a regulatory and safety problem. A [2022 review in PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC9577733/) noted that standardization of validation frameworks for healthcare digital twins remains an open challenge. This is not a solved problem. ### Bias and representativeness If the twin's underlying models were trained on data from a narrow demographic, its predictions will be unreliable for patients outside that distribution. This is the same bias problem that affects all clinical ML, but it compounds in a twin because the model runs continuously and its outputs may influence ongoing care decisions over weeks or months. ## Architecture: from source systems to simulation layer A production digital twin architecture in healthcare typically involves five layers: 1. **Data ingestion.** Connectors to EHR (FHIR, HL7v2), imaging archives, device gateways, and operational systems. Real-time or near-real-time where the use case demands it. 1. **Data normalization and storage.** A patient-centric or entity-centric data model that reconciles terminology (SNOMED, LOINC, RxNorm), handles deduplication, and manages temporal indexing. 1. **State estimation.** The component that takes raw data and infers the current state of the physical counterpart. This may involve imputation for missing values, sensor fusion, or Bayesian updating. 1. **Simulation and prediction.** The model layer. Could be physics-based (finite element models for organs), statistical (survival models, time-series forecasting), ML-based, or hybrid. The choice depends on the domain and the available training data. 1. **Interface and decision support.** Dashboards, alerts, or API endpoints that deliver twin outputs to clinicians, administrators, or downstream systems. This layer must include confidence indicators and provenance information. Building this from scratch is a large undertaking. Teams working on [AI software development](https://attractgroup.com/expertise/ai-software-development-services/) for healthcare need to plan for the integration and governance layers with the same rigor as the model itself. The simulation engine is maybe 30% of the total effort. For organizations exploring [custom AI solutions](https://attractgroup.com/services/custom-ai-solutions/) in this space, the practical advice is to start with the data layer. If you cannot reliably assemble and maintain the input data your twin needs, the sophistication of your model is irrelevant. ## Build roadmap and where the hype ends If you are considering a digital twin initiative, here is a realistic sequencing: 1. **Define the decision the twin supports.** Not "we want a digital twin." Instead: "we want to simulate the impact of staffing changes on ED throughput" or "we want to predict heart failure decompensation 48 hours earlier using continuous remote monitoring data." 1. **Audit data availability and quality.** Map every data source the twin would need. Assess coverage, latency, format, and access. This step alone may take 8-12 weeks for a clinical use case. 1. **Build the integration layer first.** Get data flowing, normalized, and stored before you build models on top of it. This work has standalone value even if the twin project changes scope. 1. **Start with a constrained model.** A twin that models one ward's patient flow is more useful than a twin that tries to model an entire hospital but never validates. Scope tightly. 1. **Plan validation from day one.** Define what "correct" means for your twin's outputs. Establish ground truth sources. Build monitoring for model drift. 1. **Iterate toward clinical use cases carefully.** Moving from operational twins to patient-level clinical twins is a step change in regulatory, safety, and validation requirements. ### Where the hype breaks down - **"A digital twin of every patient."** The data, compute, and validation requirements for individualized, continuously updated clinical twins at scale do not exist yet for most conditions. Targeted twins for specific high-risk cohorts are realistic. Universal patient twins are not. - **"Real-time" everything.** Many clinical decisions do not need sub-second model updates. Defining the actual temporal resolution your use case requires prevents over-engineering. - **Ignoring the human workflow.** A twin that produces useful predictions but delivers them in a way that does not fit clinical workflow will be ignored. Clinician input on interface design is not optional. - **Treating \[generative AI in healthcare\](https://attractgroup.com/blog/generative-ai-healthcare/) as a substitute for mechanistic models.** Large language models can help with data extraction, summarization, and interface design. They are not simulation engines. Confusing the two leads to architectures that cannot be validated. Organizations with strong [healthcare software development](https://attractgroup.com/industries/healthcare/) foundations, meaning solid EHR integration, data governance, and clinical informatics teams, are better positioned to execute on digital twin projects. The technology is less the bottleneck than the organizational readiness. ## FAQ ### How is a digital twin different from a predictive model? A predictive model takes inputs and produces an output. A digital twin maintains a persistent, updating representation of a specific physical entity and can run multiple simulations against that representation over time. The twin includes the model but also includes the data binding, state management, and feedback loop. ### What does a digital twin cost to build? Costs vary enormously by scope. An operational twin for a single department might require $200K-$500K in integration and modeling work. A patient-level clinical twin with regulatory requirements could run into the millions before validation is complete. The ongoing data pipeline and model maintenance costs are often larger than the initial build. ### Do digital twins require real-time data? Not always. An operational twin tracking weekly staffing patterns might update daily. A cardiac twin used in surgical planning might update once with pre-operative imaging. A remote monitoring twin for heart failure might need hourly or sub-hourly updates. Match the data cadence to the decision cadence. ### Are there FDA-cleared digital twin products? A small number of patient-specific simulation tools have received FDA clearance, primarily in cardiovascular planning. The regulatory pathway depends on the intended use and risk classification. Most digital twin applications in healthcare today operate in areas that do not require clearance, such as operational planning or research. ### Can we start small? Yes, and you should. An operational twin for one unit or a simulation model for one clinical pathway gives you a working data pipeline, a validation framework, and organizational learning. These are transferable to more ambitious use cases later.